{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:40:11Z","timestamp":1769272811056,"version":"3.49.0"},"reference-count":108,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,29]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease-2019 (COVID-19), a respiratory disease that varies in severity from mild to severe\/fatal. Several risk factors for severe disease have been identified, notably age, male sex, and pre-existing conditions such as diabetes, obesity, and hypertension. Several advancements in clinical care have been achieved over the past year, including the use of corticosteroids (e.g., corticosteroids) and other immune-modulatory treatments that have now become standard of care for patients with acute severe COVID-19. While the understanding of the mechanisms that underlie increased disease severity with age has improved over the past few months, it remains incomplete. Furthermore, the molecular impact of corticosteroid treatment on host response to acute SARS-CoV-2 infection has not been investigated. In this study, a cross-sectional and longitudinal analysis of Ab, soluble immune mediators, and transcriptional responses in young (65\u00a0\u2264\u00a0years) and aged (\u2265\u00a065 years) diabetic males with obesity hospitalized with acute severe COVID-19 was conducted. Additionally, the transcriptional profiles in samples obtained before and after corticosteroids became standard of care were compared. The analysis indicates that severe COVID-19 is characterized by robust Ab responses, heightened systemic inflammation, increased expression of genes related to inflammatory and pro-apoptotic processes, and reduced expression of those important for adaptive immunity regardless of age. In contrast, COVID-19 patients receiving steroids did not show high levels of systemic immune mediators and lacked transcriptional indicators of heightened inflammatory and apoptotic responses. Overall, these data suggest that inflammation and cell death are key drivers of severe COVID-19 pathogenesis in the absence of corticosteroid therapy.<\/jats:p>","DOI":"10.1002\/jlb.4cova0121-084rr","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T11:23:46Z","timestamp":1635938626000},"page":"1225-1239","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation"],"prefix":"10.1093","volume":"110","author":[{"given":"Amanda N","family":"Pinski","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California , Irvine, Irvine, California, USA"},{"name":"Center for Virus Research, University of California , Irvine, Irvine, California, USA"},{"name":"Institute for Immunology, University of California , Irvine, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara L","family":"Steffen","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University , St Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Z","family":"Zulu","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California , Irvine, Irvine, California, USA"},{"name":"Center for Virus Research, University of California , Irvine, Irvine, California, USA"},{"name":"Institute for Immunology, University of California , Irvine, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L","family":"George","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Saint Louis University , St Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandria","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University , St Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Tifrea","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California , Irvine, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J","family":"Maroney","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California , Irvine, Irvine, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute , La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute , La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H","family":"Scheuermann","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute , La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia K","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University , St Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Brien","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University , St Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhem","family":"Messaoudi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California , Irvine, Irvine, California, USA"},{"name":"Center for Virus Research, University of California , Irvine, Irvine, California, USA"},{"name":"Institute for Immunology, University of California , Irvine, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2020.24865","article-title":"COVID-19 as the leading cause of death in the United States","volume":"325","author":"Woolf","year":"2021","journal-title":"JAMA"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"e2035057","DOI":"10.1001\/jamanetworkopen.2020.35057","article-title":"SARS-CoV-2 transmission from people without COVID-19 symptoms","volume":"4","author":"Johansson","year":"2021","journal-title":"JAMA Network Open"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.3201\/eid2703.204340","article-title":"Prevalence of SARS-CoV-2 antibodies in first responders and public safety personnel, New York City, New York, USA, May-July 2020","volume":"27","author":"Sami","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab004","article-title":"The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers","author":"Lumley","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","article-title":"Clinical determinants for fatality of 44,672 patients with COVID-19","volume":"24","author":"Deng","year":"2020","journal-title":"Critical Care"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3024","article-title":"Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm","volume":"6","author":"Mudd","year":"2020","journal-title":"Sci Adv"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00263-y","article-title":"Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus-host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Reports"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2007.03.015","article-title":"SARS coronavirus and innate immunity","volume":"133","author":"Frieman","year":"2008","journal-title":"Virus Research"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nature Communications"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41392-020-00438-7","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I\/MDA-5 signaling","volume":"5","author":"Zheng","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front Immunol"},{"key":"2023032108463485100_","article-title":"Functional SARS-CoV-2-specific immune memory persists after mild COVID-19","author":"Rodda","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2\u2013specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Science Immunology"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","article-title":"The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera","author":"Steffen","year":"2020","journal-title":"bioRxiv"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1080\/22221751.2020.1823890","article-title":"SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease","volume":"9","author":"Wang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3389\/fimmu.2020.01991","article-title":"The impact of pre-existing comorbidities and therapeutic interventions on COVID-19","volume":"11","author":"Callender","year":"2020","journal-title":"Front Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10654-020-00698-1","article-title":"Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications","volume":"35","author":"Levin","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17165974","article-title":"The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression","volume":"17","author":"Romero Starke","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13048-021-00806-z","article-title":"Correction to: incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age","volume":"14","author":"O'brien","year":"2021","journal-title":"J Ovarian Res"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1073\/pnas.2011086117","article-title":"Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom","volume":"117","author":"Hamer","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"154378","DOI":"10.1016\/j.metabol.2020.154378","article-title":"Obesity in patients with COVID-19: a systematic review and meta-analysis","volume":"113","author":"Huang","year":"2020","journal-title":"Metabolism"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front Public Health"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"571416","DOI":"10.3389\/fphys.2020.571416","article-title":"Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?","volume":"11","author":"Bajaj","year":"2020","journal-title":"Front Physiol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"636118","DOI":"10.3389\/fimmu.2021.636118","article-title":"Age-related dynamics of lung-resident memory CD8(+) T cells in the age of COVID-19","volume":"12","author":"Goplen","year":"2021","journal-title":"Front Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/aging.103344","article-title":"Why does COVID-19 disproportionately affect older people?","volume":"12","author":"Mueller","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2023032108463485100_","article-title":"Impaired Cytotoxic CD8(+) T cell response in elderly COVID-19 patients","volume":"11","author":"Westmeier","year":"2020","journal-title":"mBio"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41419-020-03151-z","article-title":"Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients","volume":"11","author":"Angioni","year":"2020","journal-title":"Cell Death Dis"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s43094-021-00217-3","article-title":"Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials","volume":"7","author":"Raju","year":"2021","journal-title":"Futur J Pharm Sci"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0367","article-title":"Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients","volume":"5","author":"Iyer","year":"2020","journal-title":"Sci Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"2023032108463485100_","article-title":"Longitudinal analyses reveal age-specific immune correlates of COVID-19 severity","author":"Lewis","year":"2021","journal-title":"medRxiv"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1101\/gr.275569.121","article-title":"A machine learning method for the discovery of minimum marker gene combinations for cell-type identification from single-cell RNA sequencing","author":"Aevermann","year":"2021","journal-title":"Genome Res"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/s41467-019-10802-z","article-title":"Accurate estimation of cell-type composition from gene expression data","volume":"10","author":"Tsoucas","year":"2019","journal-title":"Nat Commun"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1093\/bioinformatics\/btw535","article-title":"ImmQuant: a user-friendly tool for inferring immune cell-type composition from gene-expression data","volume":"32","author":"Frishberg","year":"2016","journal-title":"Bioinformatics"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142004","volume-title":"Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population","author":"Klein","year":"2020"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"100126","DOI":"10.1016\/j.xcrm.2020.100126","article-title":"Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike","volume":"1","author":"Pr\u00e9vost","year":"2020","journal-title":"Cell Rep Med"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.10.051","article-title":"Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann","year":"2020","journal-title":"Lancet"},{"key":"2023032108463485100_","article-title":"The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19","author":"Robinson","year":"2020","journal-title":"Med (N Y)"},{"key":"2023032108463485100_","first-page":"e15003","article-title":"Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-a population-based cohort study","author":"Kridin","year":"2021","journal-title":"Dermatol Ther"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4269\/ajtmh.20-1110","article-title":"Factors of severity in patients with COVID-19: cytokine\/chemokine concentrations, viral load, and antibody responses","volume":"103","author":"Kwon","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"key":"2023032108463485100_","article-title":"Cytokine release syndrome in COVID-19: innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex","author":"Petrey","year":"2020","journal-title":"J Leukoc Biol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00362-20","article-title":"Clinical characteristics and immune injury mechanisms in 71 patients with COVID-19","volume":"5","author":"Wu","year":"2020","journal-title":"mSphere"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1017\/S0950268820001557","article-title":"Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19","volume":"148","author":"Kong","year":"2020","journal-title":"Epidemiol Infect"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41392-020-0211-1","article-title":"Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI Insight"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg9873","article-title":"Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19","volume":"6","author":"Thwaites","year":"2021","journal-title":"Sci Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"28336","DOI":"10.1073\/pnas.2018030117","article-title":"Transcriptional and proteomic insights into the host response in fatal COVID-19 cases","volume":"117","author":"Wu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Corticosteroids in hospitalized patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01380-20","article-title":"Respiratory syncytial virus sequesters NF-kappa B Subunit p65 to Cytoplasmic inclusion bodies to inhibit innate immune signaling","volume":"94","author":"Jobe","year":"2020","journal-title":"Journal of Virology"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.1128\/JVI.00909-08","article-title":"NF-kappaB signaling differentially regulates influenza virus RNA synthesis","volume":"82","author":"Kumar","year":"2008","journal-title":"J Virol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1128\/JVI.76.13.6800-6814.2002","article-title":"Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells","volume":"76","author":"Tian","year":"2002","journal-title":"J Virol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"19630","DOI":"10.1038\/s41598-020-76781-0","article-title":"The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19)","volume":"10","author":"Arcanjo","year":"2020","journal-title":"Sci Rep"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.4660","article-title":"Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease","volume":"238","author":"Cortjens","year":"2016","journal-title":"J Pathol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3389\/fimmu.2020.02063","article-title":"Excessive neutrophils and neutrophil extracellular traps in COVID-19","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/infdis\/jix475","article-title":"High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza a infection","volume":"217","author":"Zhu","year":"2018","journal-title":"J Infect Dis"},{"key":"2023032108463485100_","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"2023032108463485100_","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","author":"Galani","year":"2020","journal-title":"Nat Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"2023032108463485100_","article-title":"SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes","volume":"118","author":"Li","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.11.017","article-title":"Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19","author":"Bernardes","year":"2020","journal-title":"Immunity"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s42003-020-1088-9","article-title":"Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer","volume":"3","author":"Chakravarty","year":"2020","journal-title":"Commun Biol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J Infect"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12859-016-1241-0","article-title":"systemPipeR: nGS workflow and report generation environment","volume":"17","author":"Backman","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/bioinformatics\/btl056","article-title":"maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments","volume":"22","author":"Conesa","year":"2006","journal-title":"Bioinformatics"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2105-7-191","article-title":"STEM: a tool for the analysis of short time series gene expression data","volume":"7","author":"Ernst","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"2023032108463485100_","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.4COVA0121-084RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.4COVA0121-084RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/110\/6\/1225\/49464369\/jlb11030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/110\/6\/1225\/49464369\/jlb11030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T06:03:32Z","timestamp":1699769012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/110\/6\/1225\/6884689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":108,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,3]]},"published-print":{"date-parts":[[2021,11,29]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.4cova0121-084rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,11,3]]},"assertion":[{"value":"2021-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}